Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease

BACKGROUND: Premature cardiovascular disease in patients with chronic kidney disease (CKD) is not explained by traditional risk factors and oxidative stress may contribute via endothelial and vascular dysfunction. We investigated the effect of ascorbic acid on oxidative stress and vascular function...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillis, Keith, Stevens, Kathryn K, Bell, Elizabeth, Patel, Rajan K, Jardine, Alan G, Morris, Scott T W, Schneider, Markus P, Delles, Christian, Mark, Patrick B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Cardiovascular Disease in CKD
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070083/
https://www.ncbi.nlm.nih.gov/pubmed/30094018
http://dx.doi.org/10.1093/ckj/sfx158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070083/
https://www.ncbi.nlm.nih.gov/pubmed/30094018
http://dx.doi.org/10.1093/ckj/sfx158

Ejemplares similares